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ABSTRACT
Histone modifications play important roles in
chromatin remodeling, gene transcriptional regula-
tion, stem cell maintenance and differentiation.
Alterations in histone modifications may be linked
to human diseases especially cancer. Histone
modifications including methylation, acetylation
and ubiquitylation probed by ChIP-seq, ChIP-chip
and qChIP have become widely available. Mining
and integration of histone modification data can be
beneficial to novel biological discoveries. There has
been no comprehensive data repository that is
exclusive for human histone modifications. There-
fore, we developed a relatively comprehensive
database for human histone modifications. Human
Histone Modification Database (HHMD, http://
bioinfo.hrbmu.edu.cn/hhmd) focuses on the
storage and integration of histone modification
datasets that were obtained from laboratory
experiments. The latest release of HHMD incor-
porates 43 location-specific histone modifications
in human. To facilitate data extraction, flexible
search options are built in HHMD. It can be
searched by histone modification, gene ID, func-
tional categories, chromosome location and cancer
name. HHMD also includes a user-friendly visualiza-
tion tool named HisModView, by which genome-
wide histone modification map can be shown.
HisModView facilitates the acquisition and visualiza-
tion of histone modifications. The database also has
manually curated information of histone modifica-
tion dysregulation in nine human cancers.
INTRODUCTION
Eukaryotic DNA is packaged into chromatin incor-
porating repeating nucleosomes by wrapping DNA
around core histones (H2A, H2B, H3 and H4). In mam-
malian cells, the N-terminal tail of histone is subject
to many chemical modiﬁcations such as methylation,
acetylation, ubiquitylation, phosphorylation and ADP-
ribosylation. Histone modiﬁcations provide accessible
targets for eﬀectors such as histone methyltransferase
and acetyltransferase (1) and have diﬀerent impact on
chromatin structure and gene transcription, depending
on the types and locations of the modiﬁcations (2,3).
Currently, methyl-, acetyl- and ubiquityl-groups among
various modiﬁcation types have been studied mainly
by ChIP-based technologies. For speciﬁc loci at the
N-terminal tails of arginines and lysines of histone, up
to three methyl-groups can be added. Histone methylation
types at diﬀerent locations have been ascribed to either
activating or repressive functions (4). For example,
H3K4me3 is positively correlated with gene expression,
while H3K9me3 is implicated in heterochromatin forma-
tion and gene silencing (5). The normal pattern of
histone modiﬁcations is vital for chromatin stability and
transcriptional regulation (5). Disturbed changes of
histone modiﬁcations may be correlated with cancer (6).
RAR2 promoter is silenced by H3K27me3 enrichment
speciﬁcally in prostate cancer without DNA hyper-
methylation dependence (7). ChIP-based experiments
including ChIP-seq, ChIP-chip and qChIP are eﬃcient
at probing histone modiﬁcations, and have produced a
large amount of histone modiﬁcation data (8). It is
useful to have a repository of such data so that in-depth
data mining can be performed.
There have been a few resources for histone or histone
modiﬁcations, such as the ChromatinDB (9), Histone
Database (10–12), SysPTM (13) and HistoneHits (14).
ChromatinDB is genome-wide resource of histone modi-
ﬁcations in Saccharomyces cerevisiae. The Histone
Database focuses on histone sequences and structures
in many species. Although providing post-translational
modiﬁcation (PTM) information and modiﬁed residues
information of histone sequences and structures, the
Histone Database lacks large-scale proﬁles of histone
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ence between SysPTM and HHMD is that SysPTM is
a curated PTM platform for online query and analysis
while HHMD is a repository of large-scale histone
modiﬁcation data and also has built-in functions for
analysis and visualization. HistoneHits is a database for
systematic collections of histone mutants in yeast (14).
To the best of our knowledge, there has been no special-
ized database that focuses on histone modiﬁcations in
mammals, which hinders further systematic and in-depth
data mining. Therefore, there is need to build such a
database that dedicates to the storage and analysis of
experimental histone modiﬁcation data. A database of
this kind would be beneﬁcial to histone modiﬁcation
studies such as identiﬁcation of diﬀerential histone modi-
ﬁcation regions (D-HMRs) for a given set of histone
modiﬁcations.
Cancer has been considered as a complex disease, which
involves both genetic and epigenetic alteration. Until now
there have been several comprehensive projects dedicated
to cancer studies, including The Cancer Genome Atlas
(TCGA) (15) and a large amount of researches studying
cancer from epigenomic perspective (6,16,17). Although
DNA methylation undergoes signiﬁcant changes, other
epigenetic changes such as histone modiﬁcations also
reﬂect the tumorigenesis process (6,18). Global aberrant
histone modiﬁcation patterns in tumorigenesis provide
novel potential of molecular screening for cancer preven-
tion, diagnosis and treatment (19,20). Tools for histone
modiﬁcation data integration and analysis are still
needed for cancer biomarker identiﬁcation.
We developed the human histone modiﬁcation database
(HHMD), which is available at http://bioinfo.hrbmu.edu
.cn/hhmd or http://www.hhmd.org. HHMD focuses on
the storage and integration of histone modiﬁcation infor-
mation from experimental data. The latest release of
HHMD provides genomic context (hg18) for histone mod-
iﬁcation alignment, which can be used to make
comparisons between genomic and epigenomic data.
HHMD incorporates a set of tools for querying
histone modiﬁcations. Five search options were provided
for advanced searches, namely histone modiﬁcation,
gene ID, functional categories, chromosome location
and cancer name. Furthermore, HHMD provides a
visualization tool—HisModView. It has the capability of
investigating histone modiﬁcations in a genomic context
by superimposing histone modiﬁcation data on DNA
methylation, GC contents and gene information.
HHMD may be a useful resource for researchers who
are interested in epigenetic regulation and computational
epigenetics in human and other species. With the in-house
data and built-in tools in HHMD, it makes D-HMRs
identiﬁcation between cancer and control possible, and
therefore beneﬁts cancer biomarker identiﬁcations.
DATA COLLECTION
HHMD contains four types of data: (i) high-throughput
histone modiﬁcations, (ii) MeDIP methylation, (iii)
curated information of aberrant histone modiﬁcations,
genes and cancers and (iv) GC contents, RefSeq gene
(21) and other genomic annotations.
A total of 43 histone modiﬁcation types (Table 1)
classiﬁed by histone types have been included in the
current release of HHMD. Speciﬁcally, there are 228
high-throughput histone modiﬁcation datasets by
manual conﬁrmation. Each dataset is assigned a unique
HM ID (e.g. HM-26). All histone modiﬁcations were
collected from biological experiments, including high-
throughput datasets and curated information from litera-
ture. All the high-throughput datasets were probed from
ChIP-based technology. Among these datasets, 81 were
from ChIP-chip, 87 from ChIP-seq and 55 from qChIP.
Summarized ChIP-seq data ﬁles derived from tag-based
bed ﬁles with window size of 200bp were used to speed
up HHMD. Histone H3, the most sequenced type,
associates with 155 datasets. There are 50 datasets for
H4, 11 for H2A and six for histone H2B. Regarding
modiﬁcation types, 122 datasets are methylation-related,
87 of acetylation-related and 1 of ubiquitylation-related.
High-throughput datasets were collected from various
institutes and websites (Table 2). An interface form for
submission of new histone modiﬁcation information was
also provided in HHMD.
To investigate the relationships between histone
modiﬁcations and DNA methylation, HHMD integrated
Table 1. List of histone modiﬁcations for 228 high-throughput datasets
Histone
type
Histone modiﬁcations
H2A
b H2AK5ac, H2AK9ac, H2AZ
H2B
b H2BK120ac, H2BK12ac, H2BK20ac, H2BK5ac, H2BK5me1,
UbH2B
a
H3
b H3K14ac, H3K18ac, H3K23ac, H3K27ac, H3K27me1,
H3K27me2, H3K27me3, H3K36ac, H3K36me1,
H3K36me3, H3K4ac, H3K4me1, H3K4me2, H3K4me3,
H3K79me1, H3K79me2, H3K79me3, H3K9ac, H3K9me1,
H3K9me2, H3K9me3, H3R2me1, H3R2me2, H3ac
a
H4
b H4K12ac, H4K16ac, H4K20me1, H4K20me3, H4K5ac,
H4K8ac, H4K91ac, H4Kac
a,H4R3me2, H4ac
a
aNon-speciﬁc antibodies are used.
bThe list is classiﬁed according to histone types.
Table 2. List of institutes and websites of high-throughput datasets
used in this database
Institute/project Website
UCSC http://genome.ucsc.edu/cgi-bin/
hgTables
ENCODE http://hgdownload.cse.ucsc.edu/
goldenPath/hg18/wgEncode
BroadChipSeq/
Canada’s Michael Smith
Genome Sciences Centre
http://www.bcgsc.ca/data/histone-
modiﬁcation
Laboratory of Molecular
Immunology, National Heart,
Lung and Blood Institute, NIH
http://dir.nhlbi.nih.gov/Papers/lmi/
epigenomes/hgtcell.aspx
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The methylation data comprises information from
16 tissues including GM06990 cell line data (23).
The functional and genomic annotations of the genes
in HHMD were obtained from various databases
[i.e. NCBI (24), UCSC (25), GO (Gene Ontology) (26),
UniProt (14), Aﬀymetrix probe ID, KEGG (27), RefSeq
Protein (28), OMIM (29), GI, UniGene (30), PIR (31) and
Ensembl (32)].
To elucidate the interplay of histone modiﬁcations
and cancer types, two strategies were introduced. First,
we collected a panel of aberrant histone modiﬁcations in
various human cancer types from the literature by manual
curation. The current version compiled 833 curated
relationships involving 17 human histone modiﬁcations
and 555 genes that are related to nine human cancers.
Among these relationships, 588 were from ChIP-chip
and 237 were from ChIP-PCR. The nine cancers are
gastric, ovarian, colon, leukemia, prostate, lymphoid,
breast, lung and pancreatic cancer. HHMD has
imbedded search functions that can be used to query
human transcript IDs (21) and oﬃcial gene symbols.
Second, HHMD includes several high throughput
aberrant histone modiﬁcation data such as K562,
GM06990 and HeLa cell lines. An interface was also
built for submission of cancer-related histone modiﬁcation
information.
DATABASE USAGE
HHMD is a highly cross-linked database, which facilitates
data acquisition and visualization. The overview of
HHMD and two result pages are shown in Figure 1.
Figure 1A presents three starting points of HisModView
and ﬁve search options. To visually understand the data in
HHMD, HisModView and searching tools are fully cross-
linked. Search results can be downloaded from result
pages of HisModView (Figure 1B), or reviewed oﬄine
(Figure 1C). In this way, users can analyze data more
eﬃciently. For example, users can start by searching
cancer name and visualize the genes in HisModView and
then download the speciﬁc histone modiﬁcation data in
deﬁned genomic range for further review.
HHMD supports ﬂexible query for various histone
modiﬁcations and related genomic and functional
annotations by providing ﬁve search tools. Taking the
histone modiﬁcation search as an example, users can
specify the query options such as cytogenetic position,
histone modiﬁcation, technology, tissue, etc. For new
users, histone modiﬁcation search is the suggested
option. If interested in speciﬁc datasets, they should
query by HM IDs. For example, users can enter the
page ‘search by histone modiﬁcation’ and input ‘HM-26’
in the textbox labeled ‘Histone modiﬁcation search by
ID:’, and then proceed. The sample result page is shown
in Figure 1C, where a download icon and a HisModView
icon are available. Functional categories search is a
speciﬁc module dedicated to study the relationships
between histone modiﬁcation patterns and functional
classiﬁcations. Users who are interested in the histone
modiﬁcation distribution for genes of similar functions
may ﬁnd this module helpful. For example, users inter-
ested in KEGG pathway: hsa00030 can select
‘H3K4me3’ or other options from the pull-down menu
‘Histone modiﬁcation:’, then type ‘hsa00030’ in the
search ﬁeld of KEGG ID and leave others as default.
In this case, a report of six genes annotated with
hsa00030 and 26 histone modiﬁcation summaries will be
returned.
As an eﬃcient visualization tool, HisModView allows
users to browse histone modiﬁcations and genomic
annotations in the context of human genome (hg18).
A snapshot of HisModView is shown in Figure 1B.
Users can start HisModView from ‘Start by Cytogenetic
map’, ‘Start by RefSeq Gene ID’ or ‘Start by Chromo-
some Location’. The HisModView result page has
four sections, namely histone modiﬁcation, MeDIP
methylation, GC contents and RefSeq gene annotations.
Labels and histograms of histone modiﬁcations are
displayed in histone modiﬁcation section for each
genomic track. For each label, the description of the
tissue and histone modiﬁcation type is available and
can be displayed by moving the mouse over the label.
To study the relationships between histone modiﬁcations
and DNA methylation, we have integrated a panel of
methylation data from 16 tissues generated by MeDIP
into the HisModView tool. In this section, methylation
data is represented as matrices, each element within
represents one ROI [region of interest, deﬁned by
Rakyan et al. (23)] and color coding represents diﬀerent
methylation level (from yellow to blue, represents from
0 to 100% methylation). Links to another epigenetic
database for Homo Sapiens: MethyCancer (33) are avail-
able. The description of ROI, tissue type and the
methylation level are also available in the popup menus.
A detailed annotation report will be brought up by
clicking any of the gene structures in RefSeq genes
section. The gene structures such as introns and exons
can be characterized for a speciﬁc gene and the range
for viewing can be adjusted by centering on a speciﬁc gene.
DATABASE IMPLEMENTATION
HHMD was developed using J2EE. It was built using JSP,
Struts and the Java connection pool Proxool. HHMD is
running on an Apache Tomcat web server and a MySQL
server. The scripts for data analysis were written in JAVA,
which are available on HHMD website.
DISCUSSION AND FUTURE DEVELOPMENT
Recent studies of histone modiﬁcation co-localization
suggested that the co-localized histone modiﬁcations
may mark functionally important regions. Co-localized
histone modiﬁcations can provide speciﬁc cubic targets
for biological eﬀectors (34,35). To date, co-localization
of H3K4me3 (activating) and H3K27me3 (repressive) is
the most studied co-localized pair of markers, which has
been ascribed to the developmental control of ES cells
(36,37). Yet, identiﬁcation of more co-localized histone
Nucleic Acids Research, 2010,Vol.38, Database issue D151modiﬁcation pairs with functionalities is still of great
interest. We used H3K4me3 and H3K9me3 proﬁles
(38,39) in HHMD to further study the relationships
between histone modiﬁcation co-localization and gene
function. H3K4me3 is a histone modiﬁcation type
associated with relaxed chromatin structure and active
transcription, while H3K9me3 is a marker associated
with heterochromatin formation, gene imprinting and
repressive transcription (3,4). Signiﬁcant imbalance of
co-localized H3K4me3 and H3K9me3 is also suggested
to have inﬂuences on developmental processes. We sum-
marized the distribution of co-localization of H3K4me3
and H3K9me3 (repressive) from resting CD4+T cells to
explore histone modiﬁcation co-localization patterns in
genomic context. As shown in Figure 2A–C, H3K4me3
and H3K9me3 co-localized regions (200 bp window size)
reveal intermediate genomic pattern which seems to be
contributed by both H3K4me3 and H3K9me3. The obser-
vation is in good agreement with the ﬁndings that
methylation of H3 Lys4 and Lys9 play the contrary
Figure 1. Screenshot showing the interrelation of tools in HHMD. Users can start search by ‘Search’ menu or start directly from ‘HisModView’
menu. (A) Screenshot showing the starting points of the searching and visualization tools. HHMD oﬀers ﬁve advanced search options, namely search
by histone modiﬁcation, search by gene ID, search by functional categories, search by chromosome location and by cancer name. (B) Screenshot
showing the HisModView tool. Users can view histone modiﬁcations aligned by human genomic coordinates (hg18). Meanwhile, genomic
annotations such as GC contents and RefSeq genes and MeDIP methylation data can also be visualized. Users can ﬁne-tune the genomic
regions by left/right shifting or zooming in/out. Users can hover on the the texts of histone modiﬁcation types to gain further details. Users are
allowed to download the histone modiﬁcations data of the present range. Users who are interested in genomic annotations can get details from pop-
up menus. (C) Screenshot showing the ‘Search by histone modiﬁcation result’ when specifying HM ID: HM-26. Users can either download the
histone modiﬁcations data or visualize the data in HisModView.
D152 Nucleic AcidsResearch, 2010, Vol.38,Database issueroles in chromatin regulation (35,40). The genes occupied
by co-localized H3K4me3 and H3K9me3 are exempliﬁed
in Supplementary ﬁles, from which we ﬁnd that
protocadherin alpha gene cluster is marked by such co-
localization.
HHMD is predisposed to integrate genomic and
epigenomic annotations from publicly available data-
bases. Genomic annotations such as RefSeq genes, GC
contents and various epigenomic annotations including
histone modiﬁcations and DNA methylation data were
compiled in HHMD. Users can access the data by
searching and investigating histone modiﬁcations using
HisModView and oﬄine analysis tools.
HisModView is a visualization tool for data proﬁling
and comparison, which makes the identiﬁcation of
variable histone modiﬁcation regions in multiple tissues
feasible. Virtual analysis tools such as D-HMRs identiﬁ-
cation and other analysis functions are to be integrated in
a later release. A standalone version of HHMD that
supports complex calculation will be released.
As a resource to study the potential function of histone
modiﬁcation markers, HHMD could be extended with
utilities for identiﬁcation of cancer-related histone modi-
ﬁcation markers for candidate genes. We will continue to
investigate the relationships between histone modiﬁcations
and other diseases in addition to cancer. Since histone
modiﬁcations in other species are also accumulating, we
will extend the research scope to build speciﬁc databases
for histone modiﬁcations in other species as well.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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